We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Genzyme Sues Lupin Over Generic Renagel

Law360 (March 6, 2009, 12:00 AM EST) -- Biotechnology company Genzyme Corp. has sued Lupin Pharmaceuticals Inc. to prevent it from marketing a generic version of Renagel, a drug used to treat serum phosphorus in chronic kidney disease patients on dialysis.

In a complaint filed Friday with the U.S. District Court for the District of Delaware, Cambridge, Mass.-based Genzyme accused Lupin of patent infringement.

According to the complaint, Lupin – a subsidiary of the Indian drug manufacturer Lupin Ltd. – infringed four of Genzyme's patents by filing an abbreviated new drug application for sevelamer...
To view the full article, register now.